Long-Term Update of NRG/RTOG 0522: A Randomized Phase 3 Trial of Concurrent Radiation and Cisplatin With or Without Cetuximab in Locoregionally Advanced Head and Neck Cancer
Jimmy J. Caudell, Pedro A. Torres‐Saavedra, D.I. Rosenthal, Rita Axelrod, Phuc Félix Nguyen‐Tan, Eric J. Sherman, Randal S. Weber, James M. Galvin, Adel K. El‐Naggar, André Konski, Michelle Echevarria, Neal Dunlap, George Shenouda, Anurag K. Singh, Jonathan J. Beitler, Adam Garsa, James A. Bonner, Adam S. Garden, Özer Algan, Jonathan Harris, Quynh‐Thu Le
Topics & Concepts
CetuximabMedicineHead and neck cancerHazard ratioCommon Terminology Criteria for Adverse EventsOncologyInternal medicineRadiation therapyConfidence intervalRandomized controlled trialCisplatinCancerChemotherapyColorectal cancerHead and Neck Cancer StudiesHead and Neck Surgical OncologyOral health in cancer treatment